ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
77 hedge funds and large institutions have $247M invested in Orchard Therapeutics plc American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
7% less capital invested
Capital invested by funds: $265M → $247M (-$17.8M)
78% less call options, than puts
Call options by funds: $237K | Put options by funds: $1.05M
Holders
77
Holding in Top 10
2
Calls
$237K
Puts
$1.05M
Top Buyers
| 1 | +$3.51M | |
| 2 | +$2.46M | |
| 3 | +$1.62M | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$1.14M |
| 5 |
Goldman Sachs
New York
|
+$1.01M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$7.69M | |
| 3 | -$7.53M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.01M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$2.78M |